Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients

被引:75
作者
Wentholt, IM
Vollebregt, MA
Hart, AA
Hoekstra, JB
DeVries, JH
机构
[1] Acad Med Ctr, Dept Internal Med, NL-1100 AD Amsterdam, Netherlands
[2] Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 AD Amsterdam, Netherlands
关键词
D O I
10.2337/diacare.28.12.2871
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - We examined the reliability of two continuous glucose sensors in type 1 diabetic patients at night and during rapid glucose excursions and verified the hypothesized nocturnal hypoglycemic drift of the needle-type sensor (CGMSgold) and delay of the microchalysis sensor (GlucoDay). RESEARCH DESIGN AND METHODS - Blood was sampled overnight twice per hour in 13 patients. Rapid-acting insulin was given subcutaneously 30 min after breakfast. Sampling once per minute started 45 min after breakfast and 75 min After insulin injection for 30 min, with the aim of determining peak and nadir glucose values. Mean absolute differences (MADs) between sensor and blood glucose values were calculated. Sensor curves were modeled for all patients using linear regression. Horizontal and vertical shifts of sensor curves from the blood glucose curves were assessed. A vertical shift indicates sensor drift and a horizontal shift sensor delay. RESULTS- Drift was minimal in the needle-type and microdialysis sensors (-0.02 and - 0.04 mmol/l). Mean +/- SD delay was 7.1 +/- 5.5 min for the microdialysis sensor (P < 0. 001). MAD was 15.0% for the needle-type sensor and 13.6% for the microdialysis sensor (P = 0.013), After correction for the 7-min delay, the microdialysis MAD improved to 11.7% (P < 0.0001). CONCLUSIONS - The microdialysis sensor was more accurate than the needle-type sensor, with or without correction for a 7-min delay. In contrast to the previous version, the current needle-type sensor did not exhibit nocturnal hypoglycemic drift. Continuous subcutaneous glucose sensors are valuable adjunctive tools for glucose trend analyses. However, considering the large MADs, individual sensor values should be interpreted with caution.
引用
收藏
页码:2871 / 2876
页数:6
相关论文
共 17 条
[1]   COMPARING METHODS OF MEASUREMENT - WHY PLOTTING DIFFERENCE AGAINST STANDARD METHOD IS MISLEADING [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1995, 346 (8982) :1085-1087
[2]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[3]   Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor [J].
Boyne, MS ;
Silver, DM ;
Kaplan, J ;
Saudek, CD .
DIABETES, 2003, 52 (11) :2790-2794
[4]  
Childs BP, 2005, DIABETES CARE, V28, P1245
[5]   EVALUATING CLINICAL ACCURACY OF SYSTEMS FOR SELF-MONITORING OF BLOOD-GLUCOSE [J].
CLARKE, WL ;
COX, D ;
GONDERFREDERICK, LA ;
CARTER, W ;
POHL, SL .
DIABETES CARE, 1987, 10 (05) :622-628
[6]  
Gross T M, 2000, Diabetes Technol Ther, V2 Suppl 1, pS19
[7]   Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs [J].
Guerci, B ;
Floriot, M ;
Böhme, P ;
Durain, D ;
Benichou, M ;
Jellimann, S ;
Drouin, P .
DIABETES CARE, 2003, 26 (03) :582-589
[8]  
Harrell FE Jr, 2001, REGRESSION MODELING
[9]   Risky delay of hypoglycemia detection by glucose monitoring at the arm [J].
Jungheim, K ;
Koschinsky, T .
DIABETES CARE, 2001, 24 (07) :1303-1304
[10]  
KEENOY BM, 2004, DIABETES METAB RE S2, V20, pS24